Stories
Stories
Moderna Announces Promising Vaccine Trial Results
Stéphane Bancel (MBA 2000, AMP 170)
Photo by Richard Howard
Stéphane Bancel (MBA 2000, AMP 170)
Photo by Richard Howard
Moderna released promising news on the progress of their coronavirus vaccine this morning, noting that trials showed it to be 94.5% effective. “In this pandemic, what has been awful from a public health standpoint, an economic standpoint, is the worry people have to get so sick they have to go to the hospital—so sick they have to get to the ICU and have a high risk of dying,” Moderna CEO Stephane Bancel (MBA 2000) told The Washington Post. “If a [vaccine] could prevent 95 percent of people to not get disease, but to not get severe disease, that would be a game-changer: the impact on hospitals, the impact on people’s psyche and the impact on deaths.”
"These are obviously very exciting results," Dr. Anthony Fauci told CNN. "It's just as good as it gets—94.5% is truly outstanding."
A December HBS Alumni Bulletin article tracks Moderna’s path to this discovery, which began in January of this year, when it developed a treatment that went concept to clinical-trial-ready in a record-breaking 42 days. The article lays out just how radically fast the Moderna development timeline has been relative to previous vaccines—which have taken up to 13 years to come to fruition. Regarding the competitors in the race to develop a vaccine, though, Bancel makes a point in the December article that is increasingly relevant today as coronavirus cases spike nationwide: “We’re not racing against each other,” he told the Bulletin. “We’re racing the virus.”
Post a Comment
Related Stories
-
- 20 Apr 2020
- HBS Alumni News
To Build Connection in Quarantine, Clubs Go Virtual
Re: David Seftel (MBA 1992); Shannon Lundgren (MBA 1994); Patty Carrolo (MBA 1991); By: Margie Kelley -
- 20 Apr 2020
- Washingtonian
Framebridge Is Making Thousands of Face Shields for Frontline Workers
Re: Susan Rasmus Tynan (MBA 2003) -
- 01 May 2020
- Inc.
How Everlywell Pulled Off Its COVID-19 Pivot in Two Weeks
Re: Julia Cheek (MBA 2011) -
- 19 May 2020
- HBS Alumni News
Exploring the Economics of a Pandemic; Alumni Forums Draw Closer Online
Re: Akilah Rogers (MBA 2009); Jacqui Adams (MBA 1978); Beverly Anderson (MBA 1997); Sara Crutchfield Clarke (MBA 1997); Bob Halperin (MBA 1982); Marc Zablatsky (MBA 1992); Melissa Weiksnar (MBA 1982); Steve Rogers (MBA 1985); By: Margie Kelley
Stories Featuring Stefan Bancel
-
- 04 Jun 2020
- HBS Health Care Initiative
Perspectives in Health: Moderna - Pivoting Research and Ops During a Pandemic
Re: Stefan Bancel (MBA 2000); Srikant M. Datar (George F. Baker Professor of Administration Dean of the Faculty) -
- 17 Jun 2021
- Newsweek
A Conversation With Moderna Leader Stéphane Bancel
Re: Stefan Bancel (MBA 2000) -
- 16 Mar 2020
- WCVB-TV Boston
Moderna Announces Start of Coronavirus Vaccine Testing
Re: Stefan Bancel (MBA 2000)
